PDGFRA and neoplasm: Further categorization of PDGFRα+ CAFs revealed that PDGFRα+/SAA3 (Serum Amyloid A3)+ CAFs could enhance PDAC progression, whereas PDGFRα+ CAFs without SAA expression suppress tumour growth, attributed to Mpp6 overexpression [86].